United States

Balaji Sridharan

Amarin raises funding for heart drug, partnership worries pull down shares

Dec 06 2012

Biopharmaceutical company Amarin Corp Plc said it raised $100 million in non-equity financing that will help it form a sales force to launch its heart drug Vascepa, but disappointed investors hoping for a sale or partnership.

Sarepta's drug helps improve walking ability, shares jump

Oct 03 2012

An experimental drug improved walking ability in boys suffering from a rare degenerative disease that causes progressive muscle loss, data from a new study showed, nearly tripling the market value of its developer Sarepta Therapeutics Inc.

Alexza resubmits drug application early, shares soar

Jun 22 2012

Alexza Pharmaceuticals Inc resubmitted the marketing application for its anti-agitation treatment earlier than expected, sending its shares up as much as 47 percent.

Nektar Therapeutics sells royalties for $124 mln

Feb 29 2012

Nektar Therapeutics said it agreed to sell its future royalties on two drugs to Royalty Pharma for $124 million, to help repay debt.

Life Tech steers ahead of rivals in race for faster DNA device

Jan 10 2012

Life Technologies said it started taking orders for its "$1000 genome" device, placing the maker of life sciences tools in pole position in an industry-wide race to build the cheapest and fastest platform for gene sequencing.

World News